Results 31 to 40 of about 109,382 (263)

Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers

open access: yesFrontiers in Oncology, 2020
Objective: Oncogenic echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) (EML4-ALK) fusion proteins found in non-small cell lung cancers (NSCLC) are constitutively phosphorylated and activated by dimerization via the ...
Noriko Hirai   +5 more
doaj   +1 more source

Potential roles of synaptotagmin family members in cancers: Recent advances and prospects

open access: yesFrontiers in Medicine, 2022
With the continuous development of bioinformatics and public database, more and more genes that play a role in cancers have been discovered. Synaptotagmins (SYTs) are abundant, evolutionarily conserved integral membrane proteins composed of a short N ...
Huandan Suo, Nan Xiao, Kewei Wang
doaj   +1 more source

FGFR–TACC Fusion Proteins Are Oncogenic in Glioblastoma [PDF]

open access: yesCancer Discovery, 2012
Abstract Fusion proteins combining FGFR and TACC are transforming in a subset of glioblastomas.
openaire   +1 more source

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences [PDF]

open access: yesNature, 1986
A biologically active complementary DNA clone of a transforming gene present in a human colon carcinoma contains gene sequences of both tropomyosin and a previously unknown protein tyrosine kinase. The predicted protein (641 amino acids) encoded by this oncogene seems to have been formed by a somatic rearrangement that replaced the extracellular domain
Martin-Zanca, Dionisio   +2 more
openaire   +3 more sources

Changes in TFG gene expression in bovine leucocytes transformed by Theileria annulata

open access: yesFrontiers in Veterinary Science, 2022
Theileria annulata schizont-infected host cells in culture in vitro show unlimited proliferation similar to tumor cells; thus far, T. annulata and T. parva are the only eukaryotes that have been found to transform mammalian cells (immortalized).
Hong-xi Zhao   +4 more
doaj   +1 more source

Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein [PDF]

open access: yesEpigenetics, 2020
ABSTRACT Pediatric cancers commonly harbor quiet mutational landscapes and are instead characterized by single driver events such as the mutation of critical chromatin regulators, expression of oncohistones, or expression of oncogenic fusion proteins.
Emily R. Theisen   +7 more
openaire   +5 more sources

Intrinsic Structural Disorder Confers Cellular Viability on Oncogenic Fusion Proteins

open access: yesPLoS Computational Biology, 2009
Chromosomal translocations, which often generate chimeric proteins by fusing segments of two distinct genes, represent the single major genetic aberration leading to cancer. We suggest that the unifying theme of these events is a high level of intrinsic structural disorder, enabling fusion proteins to evade cellular surveillance mechanisms that ...
Hedi Hegyi, László Buday, Peter Tompa
openaire   +5 more sources

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway [PDF]

open access: yesMolecular Cancer, 2018
The insulin-like growth factor-1 receptor (IGF1R) has been identified as a potent anti-apoptotic, pro-survival tyrosine kinase-containing receptor. Overexpression of the IGF1R gene constitutes a typical feature of most human cancers. Consistent with these biological roles, cells expressing high levels of IGF1R are expected not to die, a quintessential ...
Haim Werner   +2 more
openaire   +3 more sources

PML/RARα Destabilization by Hyperthermia: A New Model for Oncogenic Fusion Protein Degradation?

open access: yesBlood Cancer Discovery, 2021
Abstract Summary: In this issue, Maimaitiyiming and colleagues demonstrate thermic stress–induced PML/RARα oncogenic fusion protein destabilization driven by corepressor aggregation. Hyperthermia synergizes with PML/RARα degradation by arsenic trioxide (ATO) and may circumvent ATO-resistance in historic acute promyelocytic leukemia ...
Wu, Hsin Chieh   +2 more
openaire   +2 more sources

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia [PDF]

open access: yesNature Chemical Biology, 2012
Translocations involving the mixed lineage leukemia (MLL) gene result in human acute leukemias with very poor prognosis. The leukemogenic activity of MLL fusion proteins is critically dependent on their direct interaction with menin, a product of the multiple endocrine neoplasia (MEN1) gene.
Jolanta, Grembecka   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy